Exports from Indore's Special Economic Zone (SEZ) have witnessed a robust surge, crossing ₹14,000 crore in the financial year 2025-26. This 10.50 per cent increase to ₹14,302 crore demonstrates significant resilience in the regional manufacturing hub.
The strong performance was reported amid global uncertainties, including US tariff policies and ongoing geopolitical tensions in West Asia. The growth trajectory underscores the continuous strength of pharmaceutical exports originating from the zone.
Pharmaceutical Sector Drives Export Resilience
An official from the Union Ministry of Commerce and Industry confirmed that the Indore SEZ's export volume remained largely unaffected by the West Asia conflict that began in March. This stability is credited to strong previous order book pipelines from key international importers.Pharmaceuticals stand out as the primary engine driving this export success. The sector accounts for approximately 70 per cent of the total exports from the Indore SEZ. Notably, the United States remains among the top global importers of these vital medicines.
Operational Footprint of Indore SEZ
The SEZ is a sprawling industrial complex spanning 572 hectares in the Pithampur area, located near Indore. This zone serves as a critical manufacturing hub housing a total of 59 plants.The industrial mix is diverse, encompassing pharmaceuticals, packaging materials, engineering goods, textile manufacturing, and food processing. Of the 59 facilities within the SEZ, a substantial 22 are dedicated to the highly regulated pharmaceutical sector.
Outperforming Despite Global Instability
For the financial year 2024-25, the SEZ recorded total exports valued at ₹12,948 crore. The current year's surge to ₹14,302 crore highlights the zone's capacity to absorb global shocks.Despite the disruption caused by international events, such as the US and Israel attacks on Iran on February 28, which affected global energy supplies, the SEZ maintained its export momentum. This sustained growth affirms the importance of the zone to India's international trade portfolio.
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.